Lasker Winners Announced

DNA-damage response and cancer immunotherapy discoveries are among those recognized by the Albert and Mary Lasker Foundation this year.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Left to right: Stephen Elledge, Evelyn Witkin, James AllisonALBERT AND MARY LASKER FOUNDATIONEvelyn Witkin of Rutgers University in New Jersey and Stephen Elledge of the Brigham and Women’s Hospital in Boston have won the 2015 Lasker Award for basic medical research. The Albert and Mary Lasker Foundation is recognizing Witkin and Elledge for their pioneering work on the DNA-damage response. (See “Gene Silencing Is Golden,” The Scientist, August 2013; “Damage Control,” The Scientist, March 2009.)

The University of Texas MD Anderson Cancer Center’s James Allison has won the 2015 Lasker Award for clinical medical research. He is being honored for his work toward antibody-based immunotherapies for cancer. (See “Deploying the Body’s Army,” The Scientist, April 2014.)

“I’ve always considered [my work] really basic science, so it’s really quite an honor to receive the clinical award this year,” Allison said during a press conference today (September 8). “I see it in part as an acknowledgement of advances in immunotherapy . . . as a field.”

Médecins Sans Frontières (MSF, also known as Doctors Without Borders) has won this year’s Lasker-Bloomberg Public Service Award for “bold leadership in responding to the recent Ebola outbreak in Africa, and for sustained and effective frontline ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies